[HTML][HTML] Editor's Choice-efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary …

European Journal of Vascular and Endovascular …, 2014 - Elsevier
Objectives The aim was to perform a review of the efficacy and safety of new oral
anticoagulants (NOAs) in the management of venous thromboembolism (VTE). Methods …

[PDF][PDF] Editor's Choice-Efficacy and Safety of the New Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Edoxaban in the Treatment and Secondary …

SK Kakkos, GI Kirkilesis, IA Tsolakis - 2014 - researchgate.net
Objectives: The aim was to perform a review of the efficacy and safety of new oral
anticoagulants (NOAs) in the management of venous thromboembolism (VTE). Methods …

[PDF][PDF] Editor's Choice-Efficacy and Safety of the New Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Edoxaban in the Treatment and Secondary …

SK Kakkos, GI Kirkilesis, IA Tsolakis - 2014 - scholar.archive.org
Objectives: The aim was to perform a review of the efficacy and safety of new oral
anticoagulants (NOAs) in the management of venous thromboembolism (VTE). Methods …

[PDF][PDF] Efficacy and Safety of the New Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Edoxaban in the Treatment and Secondary Prevention of Venous …

SK Kakkos, GI Kirkilesis, IA Tsolakis - 2014 - cyberleninka.org
Objectives: The aim was to perform a review of the efficacy and safety of new oral
anticoagulants (NOAs) in the management of venous thromboembolism (VTE). Methods …

Efficacy and Safety of the New Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Edoxaban in the Treatment and Secondary Prevention of Venous …

SK Kakkos, GI Kirkilesis, IA Tsolakis - Journal of Vascular Surgery, 2014 - jvascsurg.org
Objectives The aim was to perform a review of the efficacy and safety of new oral
anticoagulants (NOAs) in the management of venous thromboembolism (VTE). Methods …

Editor's Choice-efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of …

SK Kakkos, GI Kirkilesis, IA Tsolakis - European Journal of Vascular …, 2014 - europepmc.org
Objectives The aim was to perform a review of the efficacy and safety of new oral
anticoagulants (NOAs) in the management of venous thromboembolism (VTE). Methods …

[PDF][PDF] Editor's Choice-Efficacy and Safety of the New Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Edoxaban in the Treatment and Secondary …

SK Kakkos, GI Kirkilesis, IA Tsolakis - 2014 - core.ac.uk
Objectives: The aim was to perform a review of the efficacy and safety of new oral
anticoagulants (NOAs) in the management of venous thromboembolism (VTE). Methods …

[引用][C] Editor's Choice-Efficacy and Safety of the New Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Edoxaban in the Treatment and Secondary …

SK Kakkos, GI Kirkilesis, IA Tsolakis - European Journal of Vascular and …, 2014 - cir.nii.ac.jp
Editor's Choice - Efficacy and Safety of the New Oral Anticoagulants Dabigatran, Rivaroxaban,
Apixaban, and Edoxaban in the Treatment and Secondary Prevention of Venous …

Editor's Choice-efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of …

SK Kakkos, GI Kirkilesis… - European journal of …, 2014 - pubmed.ncbi.nlm.nih.gov
Objectives The aim was to perform a review of the efficacy and safety of new oral
anticoagulants (NOAs) in the management of venous thromboembolism (VTE). Methods …

Editor's Choice-Efficacy and Safety of the New Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Edoxaban in the Treatment and Secondary Prevention of …

SK Kakkos, GI Kirkilesis, IA Tsolakis - European Journal of Vascular & …, 2014 - infona.pl
The aim was to perform a review of the efficacy and safety of new oral anticoagulants
(NOAs) in the management of venous thromboembolism (VTE). This was a systematic …